Clinical Trials

Showing trials with last updates posted in 2026.

NCT01272037 | ACTIVE_NOT_RECRUITING | PHASE3
5018 participants

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2011-02-28
Completion:
2023-02-01
Conditions
  • Breast Ductal Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Multicentric Breast Carcinoma
  • Multifocal Breast Carcinoma
  • Synchronous Bilateral Breast Carcinoma
Interventions
  • DRUG
  • OTHER
NCT01224704 | COMPLETED | NA
75 participants

Water Deprivation Protocol

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2010-10-19
Completion:
2018-09-09
Conditions
  • Obesity
Interventions
  • OTHER
No Results Yet
NCT01081262 | ACTIVE_NOT_RECRUITING | PHASE3
50 participants

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2010-10-12
Completion:
2015-02-25
Conditions
  • Borderline Ovarian Mucinous Tumor
  • Ovarian Mucinous Cystadenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Stage IA Fallopian Tube Cancer AJCC v6 and v7
  • Stage IA Ovarian Cancer AJCC v6 and v7
  • Stage IB Fallopian Tube Cancer AJCC v6 and v7
  • Stage IB Ovarian Cancer AJCC v6 and v7
  • Stage IC Fallopian Tube Cancer AJCC v6 and v7
  • Stage IC Ovarian Cancer AJCC v6 and v7
  • Stage IIA Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIA Ovarian Cancer AJCC V6 and v7
  • Stage IIB Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIB Ovarian Cancer AJCC v6 and v7
  • Stage IIC Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIC Ovarian Cancer AJCC v6 and v7
  • Stage IIIA Fallopian Tube Cancer AJCC v7
  • Stage IIIA Ovarian Cancer AJCC v6 and v7
  • Stage IIIB Fallopian Tube Cancer AJCC v7
  • Stage IIIB Ovarian Cancer AJCC v6 and v7
  • Stage IIIC Fallopian Tube Cancer AJCC v7
  • Stage IIIC Ovarian Cancer AJCC v6 and v7
  • Stage IV Fallopian Tube Cancer AJCC v6 and v7
  • Stage IV Ovarian Cancer AJCC v6 and v7
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
NCT00588770 | ACTIVE_NOT_RECRUITING | PHASE3
403 participants

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2008-08-08
Completion:
2018-06-05
Conditions
  • Neck Squamous Cell Carcinoma of Unknown Primary
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Verrucous Carcinoma
  • Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
  • Recurrent Neck Squamous Cell Carcinoma of Unknown Primary
  • Recurrent Oral Cavity Verrucous Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Recurrent Salivary Gland Carcinoma
  • Recurrent Sinonasal Squamous Cell Carcinoma
  • Salivary Gland Squamous Cell Carcinoma
  • Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IV Major Salivary Gland Cancer AJCC v7
  • Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
  • Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IVA Major Salivary Gland Cancer AJCC v7
  • Stage IVA Oral Cavity Cancer AJCC v6 and v7
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7
  • Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
  • Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IVB Major Salivary Gland Cancer AJCC v7
  • Stage IVB Oral Cavity Cancer AJCC v6 and v7
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7
  • Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
  • Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IVC Major Salivary Gland Cancer AJCC v7
  • Stage IVC Oral Cavity Cancer AJCC v6 and v7
  • Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7
  • Tongue Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
NCT00569127 | ACTIVE_NOT_RECRUITING | PHASE3
427 participants

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2007-12-01
Completion:
2015-01-01
Conditions
  • Colorectal Neuroendocrine Tumor G1
  • Gastric Neuroendocrine Tumor G1
  • Neuroendocrine Neoplasm
  • Neuroendocrine Tumor
  • Neuroendocrine Tumor G2
Interventions
  • BIOLOGICAL
  • OTHER
  • DRUG
NCT00310180 | ACTIVE_NOT_RECRUITING | PHASE3
10273 participants

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2006-04-07
Completion:
2018-03-02
Conditions
  • Breast Adenocarcinoma
  • Hormone Receptor Positive
  • Stage IA Breast Cancer AJCC v7
  • Stage IB Breast Cancer AJCC v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
  • Stage IIIB Breast Cancer AJCC v7
Interventions
  • DRUG
  • OTHER
  • RADIATION
Previous
Sorted by latest updates
Next
Showing 40 trials per page